Congress eyes sunshine on pharma's ties to fast-growing 'stealth' prescribers

Two U.S. senators introduced a bill last week meant to close a loophole in the Sunshine Act--and add a rapidly burgeoning group of healthcare providers to the database of payments from pharma and devicemakers. The bipartisan pair, Sen. Charles Grassley (R-IA) and Sen. Richard Blumenthal (D-CT), want to add "physician assistants, nurse practitioners, and other advance practice nurses" to the Open Payments database, which tracks pharma's gifts and other payments to doctors. PAs and nurses are among a fast-growing group of "stealth" prescribers that drugmakers sometimes overlook in marketing their meds, consultants have said. More from FiercePharmaMarketing

Suggested Articles

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

It’s been a big year for Bristol's Opdivo-Yervoy combo in lung cancer, but with new mesothelioma data in hand, the duo isn’t done making headlines.

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.